Accumetrics, Inc. Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test
4/16/2013 7:19:35 AM
More...
|
Accumetrics, Inc. VerifyNow II System Achieves CE Mark
12/27/2012 8:26:12 AM
More...
|
Accumetrics, Inc. Release: 8500+ Patient Trial Validates Association Between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012
10/26/2012 7:50:16 AM
More...
|
Accumetrics, Inc.’ VerifyNow System Receives Health Canada License for Clinical Use
8/8/2012 10:26:28 AM
More...
|
Accumetrics, Inc. Release: Platelet Reactivity Considerations Center Stage at American College of Cardiology.12
3/26/2012 6:44:33 AM
More...
|
Accumetrics, Inc. Release: Platelet Reactivity Testing Included in 2011 Guideline Recommendations from European Society of Cardiology
9/7/2011 10:58:30 AM
More...
|
New CE Marked Prognostic Claim for Accumetrics, Inc.'s VerifyNow P2Y12 Test
5/17/2011 9:51:12 AM
More...
|
Accumetrics, Inc. Signs National Distribution Agreement with Cardinal Health, Inc. (CAH)
5/11/2011 8:06:59 AM
More...
|
Accumetrics, Inc. Signs National Distribution Agreement with Cardinal Health, Inc. (CAH)
5/11/2011 6:43:26 AM
More...
|
Accumetrics, Inc. Announces Publication of GRAVITAS Primary Results in JAMA
3/16/2011 7:51:01 AM
More...
|
|